CN106902150A - Co-Q10 purple perilla soft capsule prescription and preparation method - Google Patents

Co-Q10 purple perilla soft capsule prescription and preparation method Download PDF

Info

Publication number
CN106902150A
CN106902150A CN201710157886.4A CN201710157886A CN106902150A CN 106902150 A CN106902150 A CN 106902150A CN 201710157886 A CN201710157886 A CN 201710157886A CN 106902150 A CN106902150 A CN 106902150A
Authority
CN
China
Prior art keywords
soft capsule
purple perilla
glue
content
raw material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710157886.4A
Other languages
Chinese (zh)
Inventor
金铉煜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huanan Xian purple food science and Technology Co Ltd
Original Assignee
Huanan Xian Purple Food Science And Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huanan Xian Purple Food Science And Technology Co Ltd filed Critical Huanan Xian Purple Food Science And Technology Co Ltd
Priority to CN201710157886.4A priority Critical patent/CN106902150A/en
Publication of CN106902150A publication Critical patent/CN106902150A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535Perilla (beefsteak plant)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A kind of Co-Q10 purple perilla soft capsule prescription and preparation method.Content is Co-Q10, the vitamin E of 30g, the Purple Perilla Seed Oil of 369g, the beeswax composition of 72g of 30g, soft capsule skin is the burnt sugar coloring composition of gelatin, the glycerine of 117g, the purified water of 235g and the 11.2g of 235g, the soft capsule weight that content and soft capsule skin proportioning are produced is 0.5g/, immunity is the defense mechanism of human body itself, it is any foreign matter (virus, bacterium etc.) of human bioequivalence and the external intrusion of elimination, processes the ability of aging, damage, death, the own cells of denaturation and identification and treatment vivo mutations cell and virus infected cell.The body of hypoimmunity is easy to infected or cancer stricken.The present invention is applied to field of medicaments.

Description

Co-Q10 purple perilla soft capsule prescription and preparation method
Technical field:
The present invention relates to a kind of Co-Q10 purple perilla soft capsule and preparation method.
Background technology:
Immunity is the defense mechanism of human body itself, is any foreign matter (virus, the bacterium of human bioequivalence and the external intrusion of elimination Deng), process aging, damage, death, the own cells of denaturation and identification and treatment vivo mutations cell and virus infected cell Ability.The body of hypoimmunity is easy to infected or cancer stricken.
The content of the invention:
It is an object of the invention to provide a kind of Co-Q10 purple perilla soft capsule and preparation method, there is provided a kind of work(of strengthen immunity The medicine of energy.
Above-mentioned purpose is realized by following technical scheme:
Co-Q10 purple perilla soft capsule, its composition includes:Content and soft capsule skin, the parts by weight of described content raw material Than:The Co-Q10 of 25-35g, the vitamin E of 25-35g, the Purple Perilla Seed Oil of 360-375g, the beeswax of 70-75g.
Described Co-Q10 purple perilla soft capsule, the ratio of weight and number of described content raw material:The Co-Q10 of 30g, 30g Vitamin E, the Purple Perilla Seed Oil of 369g, the beeswax of 72g.
Described Co-Q10 purple perilla soft capsule, the ratio of weight and number of described soft capsule skin raw material:The gelatin of 235g, The burnt sugar coloring composition of the glycerine of 117g, the purified water of 235g and 11.2g, what said above thing and described soft capsule skin are matched somebody with somebody Soft capsule weight than producing is 0.5g/.
Described Co-Q10 purple perilla soft capsule, described enzyme Q10 purple perilla soft capsules be purification of air rank be 100,000 grades Workshop in produce, it is ensured that pilot process is pollution-free.
A kind of preparation method of described Co-Q10 purple perilla soft capsule, the method comprises the following steps:
(1)The preparation of raw material
Sieving, weighing:Co-Q10 and vitamin E are crossed into 100 mesh sieves respectively, is weighed by recipe quantity, mixed 30 minutes, it is standby;
(2)Glue is prepared
Glycerine, gelatin the putting glue tank of recipe quantity are taken, after being heated to 60-80 DEG C, the gelatin of recipe quantity is added, stirred complete to gelatin Portion dissolves, and vacuumizes, and vacuum is 0.08Mpa, 30 minutes to glue bubble-free, glue is crossed into 100 mesh sieves, in quiet in glue-storing barrel Put, glue is incubated 55 DEG C -60 DEG C;
(3)Feed liquid dispensing
Take during recipe quantity beeswax, Purple Perilla Seed Oil put preparing tank, be heated to 65 ± 2 DEG C, stirring makes beeswax melt completely, and mixing is equal It is even, oily wax liquor is obtained, 40 DEG C are then cooled to, described raw material is added, stir, 15-30 points is stirred in vacuum emulsifying machine Clock, vacuumizes, vacuum -0.05MPa~-0.08Mpa, to feed liquid bubble-free, obtains feed liquid within 20 minutes;
(4)Pelleting
Glue, feed liquid are transferred into soft capsule pellet processing machine carries out compacting pelletization, and it is 0.5g to control every loading amount of capsule 's content;
(5)Sizing
The soft capsule that will be pressed is placed in rotating cage, is shaped under conditions of 30-40%, 18-26 DEG C of temperature in relative humidity About 1.5-2.0 hours;
(6)Dry
Obtained soft capsule is uniformly laid in basin, in relative humidity under conditions of 20-30%, 15-25 DEG C of temperature Drying is qualified to moisture content.
Beneficial effects of the present invention:
1. Co-Q10 (hydroxy decyl ubiquinone) is a kind of fat-soluble antioxidant, and the present invention is added after Co-Q10, can effectively be swashed The nutrition of living person's body cell and cellular energy so that the present invention have more powerful raising body immunity, strengthen it is anti-oxidant, prolong The function such as slow aging and enhancing human activity, the present invention can effectively suppress disease of cardiovascular system.In mice serum haemolysis Plain determination experiment, antibody-producting cell detection experiment, Turnover of Mouse Peritoneal Macrophages phagocytosis chicken red blood cell experiment and mouse carbonic clearance In experiment, its result again significant difference.Think that Co-Q10 purple perilla soft capsule has the work(of strengthen immunity according to evaluation criterion Energy.
The Purple Perilla Seed Oil that is added of the present invention is a kind of natural oil of degree of unsaturation high, the present invention add perilla herb oil it Afterwards so that product of the invention is under the common synergy of active ingredient to reducing cholesterol, reduction blood fat, preventing artery congee Sample hardening, reduction cerebral thrombus and angiocardiopathy have more dauer effect;In the work of enzyme after alpha-linolenic acid intake human body The olefin(e) acid of 20 carbon 5 (EPA) and the olefin(e) acid of 22 carbon 6 (DHA) can be changed into human body under, than deep sea fish oil preferably It is free of cholesterol, and EPA and DHA has reducing blood lipid and improves the effect of memory;Foreign study shows that alpha-linolenic acid also has Antiallergy and adaptability is improved in adverse circumstance and suppresses the effect of some cancer cells.It can not independently synthesize in human body, need By food supply, the base feed channel as active ingredient of the invention.
Vitamin E(Vitamin E)It is a kind of liposoluble vitamin, the phenolic hydroxyl group on vitamin E phenyl ring is acetylation, ester It is tocopherol to be hydrolyzed to after phenolic hydroxyl group, is one of topmost antioxidant.The present invention adds vitamin E to pass through and tocopherol The promotion sex hormone secretion of alumnus with the synergy of other compositions, can be capable of, increase man's sperm motility and quantity;Maid Sub- female hormone concentration increases, and improves fecundity, prevention of miscarriage, it may also be used for prevent and treat male sterility, burn, frostbite, hair Thin angiorrbagia.There is remarkable result at aspects such as treatment climacteric metancholia, beauty.Particularly the present invention can effectively suppress eyes Lipid peroxidation reaction in crystalline lens, makes peripheral vasodilation, improves blood circulation, pre- Anti-myopic eye occurrence and development.
Invention effect is checked:
1. material
1.1 tested materials
Sample Co-Q10 purple perilla soft capsule:Recommend dose 0.5g*1/people of day.
Experimental animal cleaning grade hero Balb/c mouse:Sichuan University's West China Experimental Animal Center
1.3 key instrument B-214 electronic balances:Beijing this instrument system Co., Ltd of match many cases;Electronic digital indicator;Shanghai Sai Tuo hardware & tools Co., Ltd;Model680 type ELIASAs;BIORAD.CO2 incubators:SANYO GS;722 spectrophotometers; Shanghai analytical instrument factory.
Strengthen immunity function evaluation methods
Internal organs/weight ratio measurement, delayed allergy are carried out to Co-Q10 purple perilla soft capsule;Vola pedis thickens method;ConA The mouse spleen lymphocyte transformation experiment of induction;Mtt assay;Serum hemolysis are determined;Hemagglutination Method;Antibody-producting cell detection;Jerne Improves slide method;Turnover of Mouse Peritoneal Macrophages phagocytosis chicken red blood cell experiment;Half intracorporal method;Mouse carbonic clearance is tested;NK cells are lived Property determine;Determination of lactate dehydrogenase method.
Strengthen immunity functional evaluation result
The influence that 3.1 Co-Q10 purple perilla soft capsules are produced to mice serum blood lysin
Influence of the Co-Q10 purple perilla soft capsule of table 1 to mice serum blood lysin antibody product
Dosage(g/kg·bw) Number of animals/only Optical density difference(X±S)
Control group 11 188.37±11.89
0.28 11 193.36±11.28
0.56 10 199.19±9.46
0.84 10 202.30±9.89*
Note:* represent and control group phase P<0.01
As shown in Table 1,0.28mg/kgbw and 0.56mg/kgbw dosage groups are compared with control group mice, antibody-producting cell Number there are no significant difference(P>0.05).0.84mg/kgbw dosage groups are compared with control group mice, and antibody product has conspicuousness Difference(P<0.05).
Influence of the Co-Q10 purple perilla soft capsule of table 2 to mouse antibodies cellulation
Dosage(g/kg·bw) Number of animals/only Antibody-producting cell number/106(Splenocyte)(X±S)
Control group 11 202.18±84.03
0.28 11 223.18±102.99
0.56 11 237.73±112.70
0.84 10 387.59±97.58**
Note:* the P compared with control group is represented<0.05.
As shown in Table 2,0.28mg/kgbw and 0.56mg/kgbw dosage groups are compared with control group mice, antibody tormation There was no significant difference for cell(P>0.05);0.84mg/kgbw dosage groups are compared with control group mice, and antibody-producting cell number is equal There is significant difference(P<0.01).
Influence of the Co-Q10 purple perilla soft capsule to Turnover of Mouse Peritoneal Macrophages chicken red blood cell ability
Influence of the Co-Q10 purple perilla soft capsule of table 3 to Turnover of Mouse Peritoneal Macrophages chicken red blood cell ability
Dosage(g/kg·bw) Number of animals/only Phagocytic percentage/%(X±S) Phagocytic index(X±S)
Control group 11 30.64±2.48 1.00±0.10
0.28 11 33.09±3.71 1.05±0.13
0.56 11 33.50±3.96 1.11±0.13
0.84 10 34.90±3.09 1.14±0.11*
Note:* the P compared with control group is represented<0.05.
From table 3,0.28mg/kgbw and 0.56mg/kgbw dosage groups compared with control group mice, its abdominal cavity Macrophage to the phagocytic percentage of chicken red blood cell, phagocytic index there are no significant difference(P>0.05);0.84mg/kgbw agent Compared with control group mice, its peritoneal macrophage has conspicuousness poor the phagocytic percentage of chicken red blood cell, phagocytic index to amount group It is different(P<0.05).
Influence of the Co-Q10 purple perilla soft capsule to mouse carbonic clearance
Dosage(g/kg·bw) Number of animals/only Phagocytic index a(X±S)
Control group 10 3.75±0.45
0.28 10 3.86±0.49
0.56 10 4.26±0.47*
0.84 10 4.29±0.46*
Note:* the P compared with control group is represented<0.05.
As shown in Table 4,0.28mg/kgbw dosage groups are compared with control group mice, and its peritoneal macrophage is red to chicken thin There was no significant difference for the phagocytic percentage of born of the same parents(P>0.05);0.56mg/kgbw and 0.84mg/kgbw dosage groups and control group Mouse is compared, and its peritoneal macrophage has significant difference P to the phagocytic percentage of chicken red blood cell<0.05.
Brief description of the drawings:
Accompanying drawing 1 is technological process of production schematic diagram of the invention.
Specific embodiment:
Embodiment 1:
A kind of Co-Q10 purple perilla soft capsule prescription, its composition includes:Content and soft capsule skin, described content raw material Ratio of weight and number:The Co-Q10 of 30g, the vitamin E of 30g, the Purple Perilla Seed Oil of 369g, the beeswax composition of 72g, described flexible glue The ratio of weight and number of capsule skin raw material:The burnt sugar coloring composition of the gelatin of 235g, the glycerine of 117g, the purified water of 235g and 11.2g, with The soft capsule weight that upper described content and described soft capsule skin proportioning are produced is 0.5g/.
Embodiment 2:
Co-Q10 purple perilla soft capsule prescription according to embodiment 1, described content and described soft capsule skin composition honeybee Glue soft capsule, described bee glue soft capsule is produced in the workshop that purification of air rank is 100,000 grades, and pilot process is pollution-free.
Embodiment 3:
A kind of preparation method of the described Co-Q10 purple perilla soft capsule prescription of one of embodiment 1-2, the method includes following step Suddenly:
(1)It is prepared by raw material
Sieving, weighing:Co-Q10 and vitamin E are crossed into 100 mesh sieves respectively, is weighed by recipe quantity, mixed 30 minutes, it is standby.
(2)Glue is prepared
Glycerine, gelatin the putting glue tank of recipe quantity are taken, after being heated to 60-80 DEG C, the gelatin of recipe quantity is added, stirred complete to gelatin Portion dissolves, and vacuumizes(Vacuum is -0.08Mpa)Glue, to glue bubble-free, is crossed 100 mesh sieves, in glue-storing barrel by 30 minutes Stand, 55 DEG C -60 DEG C of glue insulation is standby.
(3)Feed liquid dispensing
Take during recipe quantity beeswax, Purple Perilla Seed Oil put preparing tank, be heated to 65 ± 2 DEG C, stirring makes beeswax melt completely, and mixing is equal It is even, obtain oily wax liquor.Then 40 DEG C are cooled to.Described raw material is added, is stirred, 15-30 points is stirred in vacuum emulsifying machine Clock, vacuumizes(Vacuum -0.05MPa~-0.08MPa)To feed liquid bubble-free, feed liquid is obtained within 20 minutes, it is standby.
(4)Pelleting
Glue, feed liquid are transferred into soft capsule pellet processing machine carries out compacting pelletization, and it is 0.5g to control every loading amount of capsule 's content.
(5)Sizing
The soft capsule that will be pressed is placed in rotating cage, is shaped under conditions of 30-40%, 18-26 DEG C of temperature in relative humidity About 1.5-2.0 hours.
(6)Dry
Obtained soft capsule is uniformly laid in basin, in relative humidity under conditions of 20-30%, 15-25 DEG C of temperature Dry 24 hours qualified with up to moisture content.
(7)Select ball
Dried soft capsule is placed in the special-shaped ball of rejecting on lamp inspection desk, big piller, bubble ball, oil leak ball etc. underproof soft Capsule.
(8)Inner packing
Packed with the medicinal polyester bottles of oral administration solid, 60 every bottle.
(9)External packing
Packaging intermediate products → put specification → fill big case → loading packing slip(One)→ joint sealing → label(Case).(It is commercially available Minimum package specification:60/bottle)
(10)Inspection, storage:
The finished product that will have been packed, randomly selects product, is tested according to the method described in quality standard and requirement, and it is qualified to check Afterwards, finished product storage.

Claims (5)

1. a kind of Co-Q10 purple perilla soft capsule, its composition includes:Content and soft capsule skin, it is characterized in that:Described content The ratio of weight and number of raw material:The Co-Q10 of 25-35g, the vitamin E of 25-35g, the Purple Perilla Seed Oil of 360-375g, 70- The beeswax of 75g.
2. Co-Q10 purple perilla soft capsule according to claim 1, it is characterized in that:The weight portion of described content raw material Number ratio:The Co-Q10 of 30g, the vitamin E of 30g, the Purple Perilla Seed Oil of 369g, the beeswax of 72g.
3. Co-Q10 purple perilla soft capsule according to claim 1 and 2, it is characterized in that:The weight of described soft capsule skin raw material Amount portion rate:The burnt sugar coloring of the gelatin of 235g, the glycerine of 117g, the purified water of 235g and 11.2g, what said above thing and The soft capsule weight that described soft capsule skin proportioning is produced is 0.5g/.
4. the Co-Q10 purple perilla soft capsule according to claim 1 or 2 or 3, it is characterized in that:Described bee glue soft capsule is Produced in the workshop that purification of air rank is 100,000 grades, it is ensured that pilot process is pollution-free.
5. the preparation method of the described Co-Q10 purple perilla soft capsule of one of a kind of claim 1-4, it is characterized in that:The method bag Include following steps:
(1)The preparation of raw material
Sieving, weighing:Co-Q10 and vitamin E are crossed into 100 mesh sieves respectively, is weighed by recipe quantity, mixed 30 minutes, it is standby;
(2)Glue is prepared
Glycerine, gelatin the putting glue tank of recipe quantity are taken, after being heated to 60-80 DEG C, the gelatin of recipe quantity is added, stirred complete to gelatin Portion dissolves, and vacuumizes, and vacuum is 0.08Mpa, 30 minutes to glue bubble-free, glue is crossed into 100 mesh sieves, in quiet in glue-storing barrel Put, glue is incubated 55 DEG C -60 DEG C;
(3)Feed liquid dispensing
Take during recipe quantity beeswax, Purple Perilla Seed Oil put preparing tank, be heated to 65 ± 2 DEG C, stirring makes beeswax melt completely, and mixing is equal It is even, oily wax liquor is obtained, 40 DEG C are then cooled to, described raw material is added, stir, 15-30 points is stirred in vacuum emulsifying machine Clock, vacuumizes, vacuum -0.05MPa~-0.08Mpa, to feed liquid bubble-free, obtains feed liquid within 20 minutes;
(4)Pelleting
Glue, feed liquid are transferred into soft capsule pellet processing machine carries out compacting pelletization, and it is 0.5g to control every loading amount of capsule 's content;
(5)Sizing
The soft capsule that will be pressed is placed in rotating cage, is shaped under conditions of 30-40%, 18-26 DEG C of temperature in relative humidity About 1.5-2.0 hours;
(6)Dry
Obtained soft capsule is uniformly laid in basin, in relative humidity under conditions of 20-30%, 15-25 DEG C of temperature Dry 24 hours qualified with up to moisture content.
CN201710157886.4A 2017-03-16 2017-03-16 Co-Q10 purple perilla soft capsule prescription and preparation method Pending CN106902150A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710157886.4A CN106902150A (en) 2017-03-16 2017-03-16 Co-Q10 purple perilla soft capsule prescription and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710157886.4A CN106902150A (en) 2017-03-16 2017-03-16 Co-Q10 purple perilla soft capsule prescription and preparation method

Publications (1)

Publication Number Publication Date
CN106902150A true CN106902150A (en) 2017-06-30

Family

ID=59187862

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710157886.4A Pending CN106902150A (en) 2017-03-16 2017-03-16 Co-Q10 purple perilla soft capsule prescription and preparation method

Country Status (1)

Country Link
CN (1) CN106902150A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108236714A (en) * 2018-01-29 2018-07-03 江苏神华药业有限公司 Alleviate physical fatigue and assist the composition and its soft capsule of reducing blood lipid
CN110269883A (en) * 2018-11-05 2019-09-24 中冠生物科技(珲春)有限公司 A kind of composition and its application in the product for preparing blood pressure lowering
CN110585266A (en) * 2019-09-18 2019-12-20 广东润和生物科技有限公司 Application of composition of perilla seed oil and coenzyme Q10
CN114009762A (en) * 2021-11-01 2022-02-08 欣安贝药业科技盐城有限公司 Coenzyme Q10 soft capsule for enhancing immunity and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101732201A (en) * 2009-12-31 2010-06-16 玉溪健坤生物药业有限公司 Reduced coenzyme Q10 essence oil and preparation method thereof
CN101810336A (en) * 2010-04-30 2010-08-25 广东仙乐制药有限公司 Chewable soft capsules and method for preparing same
CN101849971A (en) * 2010-06-08 2010-10-06 玉溪健坤生物药业有限公司 Soft capsule containing coenzyme Q10 and preparation method and application thereof
CN103083501A (en) * 2012-11-13 2013-05-08 江苏艾兰得营养品有限公司 Soft capsule preparation for preventing and treating diseases of old people
CN104983791A (en) * 2015-06-18 2015-10-21 南京邦康生物技术有限公司 Health-care product containing coenzyme Q10 and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101732201A (en) * 2009-12-31 2010-06-16 玉溪健坤生物药业有限公司 Reduced coenzyme Q10 essence oil and preparation method thereof
CN101810336A (en) * 2010-04-30 2010-08-25 广东仙乐制药有限公司 Chewable soft capsules and method for preparing same
CN101849971A (en) * 2010-06-08 2010-10-06 玉溪健坤生物药业有限公司 Soft capsule containing coenzyme Q10 and preparation method and application thereof
CN103083501A (en) * 2012-11-13 2013-05-08 江苏艾兰得营养品有限公司 Soft capsule preparation for preventing and treating diseases of old people
CN104983791A (en) * 2015-06-18 2015-10-21 南京邦康生物技术有限公司 Health-care product containing coenzyme Q10 and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
苏豹,等: "七花牌七灵宝软胶囊生产工艺", 《中国民族民间医药》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108236714A (en) * 2018-01-29 2018-07-03 江苏神华药业有限公司 Alleviate physical fatigue and assist the composition and its soft capsule of reducing blood lipid
CN108236714B (en) * 2018-01-29 2021-09-10 江苏神华药业有限公司 Composition for relieving physical fatigue and assisting in reducing blood fat and soft capsule thereof
CN110269883A (en) * 2018-11-05 2019-09-24 中冠生物科技(珲春)有限公司 A kind of composition and its application in the product for preparing blood pressure lowering
CN110585266A (en) * 2019-09-18 2019-12-20 广东润和生物科技有限公司 Application of composition of perilla seed oil and coenzyme Q10
CN114009762A (en) * 2021-11-01 2022-02-08 欣安贝药业科技盐城有限公司 Coenzyme Q10 soft capsule for enhancing immunity and preparation method thereof

Similar Documents

Publication Publication Date Title
CN106902150A (en) Co-Q10 purple perilla soft capsule prescription and preparation method
CN102771786B (en) Propolis and lucid ganoderma soft capsule with health care function and preparation method of propolis and lucid ganoderma soft capsule
CN102283386B (en) Composite camellia oil health care product with function of reducing blood fat and preparation method thereof
CN102188565B (en) Weight-losing soft capsules and preparation method thereof
CN104873561B (en) A kind of maca preparation and preparation method thereof
CN104983791A (en) Health-care product containing coenzyme Q10 and preparation method thereof
CN104323283B (en) Contain alimentation composition of Co-Q10 and preparation method thereof and application
CN112089058A (en) Soft capsule for improving immunity and preparation method thereof
CN105394749B (en) A kind of Ricipe for health care food and preparation method and application containing astaxanthin
CN106880661A (en) Pseudo-ginseng ginkgo leaf purple perilla method for producing soft capsule
CN103734581B (en) Yak milk polypeptide nutrient powder being applicable to postoperative crowd&#39;s rehabilitation and preparation method thereof
CN109172537B (en) Preparation method of fish oil soft capsules
CN107440036A (en) A kind of Halth-care composition, its preparation and preparation method for improving memory, improving eyesight
CN105942510A (en) Medical energy nutrition component applied to pregnant and lying-in women and preparation method thereof
CN107260799A (en) Vitamin E purple perilla flexible glue capsule formula and preparation method
CN106912942A (en) Lutein purple perilla method for producing soft capsule
CN103006712A (en) Bee product extract with functions of resisting oxidation and eliminating free radicals
CN107129430B (en) Method for synthesizing medium-chain triglyceride of bulk drugs
CN107029016A (en) Propolis purple perilla soft capsule and processing method
CN102488207A (en) Coenzyme Q10 soft capsule and its preparation method
CN107260800A (en) Resveratrol purple perilla soft capsule and preparation method
WO2014134834A1 (en) Composition and food comprising same and preparation method of food
CN106562937A (en) Coenzyme Q10 soft capsule and preparation method thereof
CN112715933A (en) Royal jelly capsule and preparation method thereof
CN105686005A (en) Collagen preparation and production method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20181225

Address after: 150 000 Unit 302, 299 Dongda Zhijie, Nangang District, Harbin City, Heilongjiang Province

Applicant after: Harbin Dong Zhuan Science and Technology Ltd.

Address before: 150076 Huanan County Economic Development Zone, Jiamusi City, Heilongjiang Province

Applicant before: Huanan Xian purple food science and Technology Co Ltd

SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20190521

Address after: 150 000 Huanan Economic Development Zone, Huanan County, Jiamusi City, Heilongjiang Province

Applicant after: Huanan Xian purple food science and Technology Co Ltd

Address before: 150 000 Unit 302, 299 Dongda Zhijie, Nangang District, Harbin City, Heilongjiang Province

Applicant before: Harbin Dong Zhuan Science and Technology Ltd.

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170630